Literature DB >> 20374357

Successful use of infliximab in a patient with neuro-Behçet's disease.

Gracia Maria Abalos-Medina1, Daniel Sánchez-Cano, Gonzalo Ruiz-Villaverde, Ricardo Ruiz-Villaverde, Susana Quirosa Flores, Enrique Raya Alvarez.   

Abstract

Behçet's disease (BD) is a systemic vasculitic disorder of unknown aetiology characterised by recurrent oral and often genital ulcers, which may be associated with ocular, cutaneous, articular, neurological or vascular involvement. We report a 52-year-old woman diagnosed of neuro-BD who was treated with infliximab with a dramatic response to this treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20374357     DOI: 10.1111/j.1756-185X.2009.01420.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  5 in total

Review 1.  Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.

Authors:  Marko Barešić; Mirna Reihl; Mario Habek; Nenad Vukojević; Branimir Anić
Journal:  Rheumatol Int       Date:  2018-05-17       Impact factor: 2.631

Review 2.  Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.

Authors:  Eleni I Kampylafka; Harry Alexopoulos; Marinos C Dalakas; Athanasios G Tzioufas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 3.  Update on the therapy of Behçet disease.

Authors:  Zeinab Saleh; Thurayya Arayssi
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

Review 4.  Infliximab for patients with neuro-Behcet's disease: case series and literature review.

Authors:  Afshin Borhani Haghighi; Anahid Safari; Mohammad Ali Nazarinia; Zahra Habibagahi; Saeedeh Shenavandeh
Journal:  Clin Rheumatol       Date:  2011-03-24       Impact factor: 2.980

5.  Infliximab is a plausible alternative for neurologic complications of Behçet disease.

Authors:  Burcu Zeydan; Ugur Uygunoglu; Sabahattin Saip; Onat N Demirci; Emire Seyahi; Serdal Ugurlu; Vedat Hamuryudan; Aksel Siva; Orhun H Kantarci
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-07-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.